Article Text

PDF

Involving patients with type 2 diabetes, hypertension, and hyperlipidaemia in disease management improved outcomes
  1. Pat Phillips, MBBS, MA, FRACP
  1. Queen Elizabeth Hospital
 Woodville, South Australia, Australia

    Statistics from Altmetric.com

    
 
 QUESTION: In patients with type 2 diabetes mellitus, hypertension, and hyperlipidaemia, does involvement in managing their disease improve outcomes?

    Design

    Randomised (unclear allocation concealment*), unblinded,* controlled trial with 4 years of follow up.

    Setting

    A hospital diabetes outpatient clinic in Israel.

    Patients

    141 patients who were 45–70 years age (mean age 57 y, 51% women) with type 2 diabetes, blood pressure >140 mm Hg systolic or >90 mm Hg diastolic, and hyperlipidaemia. Exclusion criteria included diabetes duration >10 years, body mass index (BMI) >35 kg/m2, smoking, serum creatinine >176 μmol/l, albumin to creatinine ratio ≥200 mg/g, and history of vascular surgery. Follow up was 91%.

    Intervention

    Patients were allocated to the participation programme (PP) (n=71) or to standard consultation (SC) (n=70). Patients in the PP group attended a 1 hour teaching session and were given detailed written instructions, and a copy of the structured consultation letter that was sent to their family doctor. They were given responsibility for complying with medications, monitoring treatment effects, requesting treatment changes, and achieving and maintaining target blood pressure, low density lipoprotein cholesterol (LDL C), haemoglobin A1c (HbA1c), and BMI (<25 kg/m2 for men and <24 kg/m2 for women). These patients had the option to initiate a visit or telephone conversation with a consultant when they needed advice. Patients in the SC group were given annual consultation with structured letters provided to their primary care physician. Patients in both groups received medical care by their primary care physicians.

    Main outcome measures

    Main outcomes were change in the glomerular filtration rate (GFR) and change in the urinary albumin to creatinine ratio. Secondary outcomes were changes in systolic and diastolic blood pressure, LDL C, and HbA1c concentrations.

    Main results

    Analysis was by intention to treat. At 4 years, the PP group had a higher mean estimated GFR (98 v 91 ml/min per 1.73 m2, p<0.05) and a lower mean urinary albumin to creatinine ratio (44 v 69 mg/g, p<0.05) than the SC group. Fewer patients in the PP group developed nephropathy (defined as an albumin to creatinine ratio >300 mg/g), new incidences of retinopathy, and cardiovascular events (table). The PP group showed lower mean systolic blood pressure (142 v 148 mm Hg, p<0.05), mean diastolic blood pressure (84 v 88 mm Hg, p<0.05), mean LDL C (114 v 124 mg/dl, p=0.01), and mean HBA1c levels (8.2% v 8.9%, p=0.04) than the SC group.

    Patient participation (PP) v standard consultation (SC) for type 2 diabetes, hypertension, and hyperlipidaemia at 4 years†

    Conclusion

    In patients with type 2 diabetes mellitus, hypertension, and hyperlipidaemia, participation in disease management improved outcomes.

    Commentary

    The study by Rachmani et al adds to the literature on the benefits of actively involving patients in self management. Study participants were selected from a diabetes outpatient clinic in an academic hospital. Although participants were referred from primary care, they were a high risk group with other cardiovascular risk factors. It is possible that the PP may not be similarly effective in primary care centres without academic input.

    Participants in the PP group were provided with individualised, detailed instructions. These participants showed clinically and statistically significant improvement in risk factor management, which led to lower blood pressure, HBA1c, and cholesterol concentration. However, interestingly, target concentrations were still not achieved.

    This study was not designed to assess such health outcomes as cardiovascular and microvascular events. Other studies, such as the United Kingdom Prospective Diabetes Study1 and the Heart Protection Study,2 have shown that changes in risk factor control (eg, blood glucose, blood pressure, and cholesterol concentrations) result in improved health outcomes.

    A worldwide trend exists towards self management of chronic disease. The recent introduction of Medicare funding in the US for diabetes education is an acknowledgment that funding organisations recognise the value of educating patients and building their capacity for self management. This study will help those designing future education programmes for managing diabetes and other chronic diseases.

    References

    View Abstract

    Footnotes

    • Source of funding: no external funding.

    • For correspondence: Professor M Ravid, Meir Hospital, Kfar-Sava, Israel. motriv{at}clalit.org.il

    • Abstract and commentary also published in ACP Journal Club

    • * See glossary.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.